Dr. Kumar Discusses Gallbladder Cancer

Patient Newsletter 2024 February

Cancer Prevention Recommendations

Multiple Myeloma, Equate EAA181

Effective Quadruplet Utilization after Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation.

Breast, ASCENT-05/ GS-US-595-6184/ AFT-65

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Patient Newsletter 2024 January

Director of Nursing Molly Ganley Talks About Reducing Your Risks for Cancer

Breast, OptimICE-pCR: A012103

This phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab.

Pamela Coffey Discusses Dealing with Cancer during the Holidays

Pamela Coffey is a Licensed Clinical Social Worker who works with cancer patients and their families at Hematology-Oncology Associat

Patient Newsletter 2023 December

Pages